6-브로모퓨린

Purine, 6-bromo-

HCID 5287830CAS 767-69-1

기본 정보

표준 SMILES
Brc1ncnc2nc[nH]c12
InChIKey
CTGFGRDVWBZYNB-UHFFFAOYSA-N
분자식
C5H3BrN4
평균 분자량
199.01 g/mol
단동위원소 질량
197.9541082

이름 및 식별자

우선 이름
Purine, 6-bromo-
IUPAC
6-bromo-7H-purine
현지명
6-브로모퓨린
영어명
6-Bromopurine
분자식
C5H3BrN4
분자량
199.01

이름 및 동의어

6-Bromopurine6-BROMO-7H-PURINE767-69-16-bromo-9H-purine6-Bromo-1H-purinePurine, 6-bromo-1H-Purine, 6-bromo-BB-127EEINECS 212-187-8NSC 45150DTXSID20227499RefChem:870374
이름 더 보기
6-브로모퓨린6-bromo-purin6-Bromopurine ,98%
1H-Purine, 6-bromo-(9CI)DTXCID70149990212-187-8MFCD000226486-Bromo purine6-Bromo-1H-purine; 6-Bromo-9H-purine; 6-Bromopurine; NSC 451506-Bromopurine, 97%6-Bromopurine, 98%

데이터베이스 식별자

CAS
767-69-1
PubChem CID
5287830
DTXSID
DTXSID20227499
EC Number
212-187-8
Nikkaji
J193.144J

물성

구조 계산 물성

XLogP
1.3
극성 표면적
54.5 Ų
수소 결합 공여자 수
1
수소 결합 수용자 수
3
회전 가능 결합 수
0
무거운 원자 수
10

실험 및 물리화학적 성질

DrugsPharmaceuticals -> Listed in ZINC15
Melting Point>300 °C

물리화학적 성질

녹는점
300 °C · >300 °C (lit.)
끓는 점
240.9 · 240.9±50.0 °C(Predicted)
밀도
2.28 · 2.28±0.1 g/cm3(Predicted)
저장 조건
2 · under inert gas (nitrogen or Argon) at 2-8°C
용해도
DMSO(약간 용해됨), 메탄올(약간 용해됨)
물리적 상태
고체

화학적 성질

Dark yellow crystalline powder

안전 및 규제

GHS 분류

GHS Classification · 4건

Warning

H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation]

P261, P264, P264+P265, P271, P280, P302+P352, P304+P340, P305+P351+P338, P319, P321, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 69 reports by companies from 5 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

유해성 정보

Hazard Classes and CategoriesSkin Irrit. 2 (100%)

안전 데이터

wgk
3
rtecs
UO7513000
HS 번호
29339900
risk_code
36/37/38
hazard_code
Xi
safety_code
26-36

화학 및 산업

응용 분야 · 3건

개요6-Bromopurine is a 6-halogenated purine nucleoside analogue. Studies have shown that 6-halogenopurine inhibits tumour growth when combined with azaserine, which may be related to the blockage of guanine nucleotide biosynthesis. The inhibitory effect of bromopurine occurs between inosine 5‘-phosphate and guanosine 5’-phosphate. 6-Bromopurine also enhances the carcinostatic activity of azaserine. In addition, 6-Bromopurine is also used as an intermediate in the synthesis of Idelalisib.

용도6-Bromopurine was used in the synthesis of 6-halopurine alkynes and corresponding triazole derivatives. 6-Bromopurine was used in the synthesis and chemical characterization of 2,3,4,5-tetrahydro-1,5-benzoxazepines-3-ol.

일반 설명6-Bromopurine enhances the carcinostatic activity of azaserine in a test system employing ascites cell forms of sarcoma 180 and Ehrlich carcinoma in vivo. 6-bromopurine nucleosides are excellent substrates for substitution reactions with N-, O-, and S-containing nucleophiles in polar solvents.

공급사50 곳

上海阿拉丁生化科技股份有限公司400-6206333 13167063860 · [email protected]
宁波振岳医药科技有限公司19817745290 · [email protected]
毕佳索(上海毕得医药科技股份有限公司)400-6005915 · [email protected]
宁波季诺化学品有限公司0574-87314919 057487319282 · [email protected]
Baoji Guokang Healthchem co.,ltd+8615604608665 15604608665 · [email protected]

관련 반응

85건

연결된 노트

불러오는 중…